Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
Raphael J. Landovitz(APLA Health), Sheldon D. Fields(Pennsylvania State University), Meredith E. Clement(Louisiana State University Health Sciences Center New Orleans), Edgar T. Overton(University of Alabama at Birmingham), Christina Psaros(Harvard University), Joseph J. Eron(University of North Carolina at Chapel Hill), Suwat Chariyalertsak(Chiang Mai University), Estelle Piwowar‐Manning(Johns Hopkins University), Steven A. Safren(University of Miami), Jeanne Marrazzo(St. Vincent's Birmingham), Shobha Swaminathan(Rutgers, The State University of New Jersey), Maoji Li(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Keren Middelkoop(Desmond Tutu HIV Foundation), Trần Việt Hà(University of North Carolina at Chapel Hill), Aditya H. Gaur(St. Jude Children's Research Hospital), Esper G. Kallás(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Nittaya Phanuphak(HIV Netherlands Australia Thailand Research Collaboration), Marcus Bryan(Family Health International 360), Craig W. Hendrix(Unknown), Jeremy Sugarman(Johns Hopkins Berman Institute of Bioethics), Peter L. Anderson(University of Colorado Denver), Cheryl Blanchette(Family Health International 360), Omar Sued(Fundación Huésped), Jonathan Lucas(Family Health International 360), Roy M. Gulick(New York University), Eileen F. Dunne, Breno Santos(UCLA Medical Center), Todd T. Brown(Johns Hopkins University), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ian Frank(Norwegian Womens Public Health Association), Pedro Gonzáles(Hospital Nacional Dos de Mayo), Hyman Scott(UCLA Medical Center), Lara E. Coelho(UCLA Medical Center), Carlos del Rı́o(Emory University), Philip A. Sullivan(Johns Hopkins University), Marcelo Losso(UCLA Medical Center), Susan H. Eshleman(Johns Hopkins University), Mark A. Marzinke(Family Health International 360), Eric S. Daar(UCLA Medical Center), Colleen F. Kelley(Emory University), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Zhe Wang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), José Valdez Madruga, Paul Richardson(Johns Hopkins University), Juan Hinojosa(Asociación para la Conservación de la Cuenca Amazónica), Robinson Cabello(Asociación Civil Impacta Salud y Educación), Jorge A. Gallardo-Cartagena(National University of San Marcos), Aida Asmelash(Family Health International 360), Leslie Cottle(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 847
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k